Russian University COVID-19 Vaccine Trials.
                     Russian University COVID-19 
Vaccine Trials
Introduction
• After more than six months of novel coronavirus outbreak, which has infected more than 12 million people 
and killed more than 500,000 people worldwide, clinical trials of the supposedly world's first coronavirus 
vaccine have been completed successfully. 
Source: India.com
About The University
• Vadim Tarasov, the head of the Center for Translational Medicine and Biotechnology, according to Russian 
news agency Sputnik, has successfully completed the clinical trials of the world's first corona virus vaccine 
on volunteers at Sechenov First Moscow State Medical University, adding that the first group of volunteers 
will be discharged on July 15 and the second on July 20.
Source: News Today
Produced by
• On June 18th, the university began clinical trials of the vaccine developed by the Russian Gamalei Institute 
of Epidemiology and Microbiology. 
• University of Sechenov has successfully completed studies of the world's first coronavirus vaccine on 
volunteers. 
Source: Llivemint
Safety Confirmation
• According to Alexander Lukashev, the director of Sechenov University's Institute of Medical Parasitology, 
Tropical and Vector-Borne Diseases, the purpose of this stage of the study was to demonstrate the 
protection of the vaccine for human health, which was successfully achieved.
Source: The Weather Channel
Further Plan
• According to Lukashev, the developer 's strategy is already evaluating the further vaccine development 
plan, including the difficulty of the epidemiological situation with the virus and the possibility of scaling up 
the production. 
Source: Pixabay
Following Universities
• Gilead Sciences, researchers at Oxford University and American pharmaceutical company Moderna are at the 
forefront of the development of a Covid-19 vaccine. 
• Gilead Sciences Inc., however, said earlier that an study showed its antiviral remdesivir helped to reduce the 
risk of death in critically ill COVID-19 patients, but warned that it needed rigorous clinical trials to validate the 
benefit.
Source: South China Morning Post
Updates of Big Brands
• In addition, the Covid-19 vaccine candidate from BioNTech SE and Pfizer Inc is expected to be ready to seek 
regulatory approval by the end of 2020, the Wall Street Journal reported on Friday, citing the chief executive 
officer of the German biotech firm.
Source: RTT News
Upcoming Expectation
• The experimental vaccine, which showed promise in early stage human trials against the rapidly spreading 
respiratory disease, is set to step into a major trial involving 30,000 healthy participants later this month, 
pending regulatory nod.
Source: Pixabay
Comments from ICMR
• ICMR also highlighted China's progress in speeding up its Covid-19 vaccine program and studies with that 
vaccine.
• According to a source, Russia's first Covid-19 vaccine, scientists said they're eyeing to launch the vaccine by 
mid-August.
Source: Wikipedia
Thanking Note
• In a pandemic situation, Sechenov University acted not only as an educational institution but also as a center 
of scientific and technological research capable of participating in the creation of such important and 
complex products as drugs
Source: sechenov.ru